Innoviva, Inc.
US ˙ NasdaqGS ˙ US45781M1018

SecurityINVA / Innoviva, Inc.
InstitutionElkfork Partners LLC
Latest Disclosed Ownership13,750 shares
Latest Disclosed Value $ 145,000
Elkfork Partners LLC ownership in INVA / Innoviva, Inc.

On November 14, 2019 - Elkfork Partners LLC filed a 13F-HR form disclosing ownership of 13,750 shares of Innoviva, Inc. (US:INVA) valued at $144,925 USD as of September 30, 2019. The entity filed a previous 13F-HR on August 13, 2019 disclosing 13,750 shares of Innoviva, Inc.. This represents a change in shares of 0.00% during the quarter. The current value of the position is $309,650 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2019-11-14 2019-09-30 13F Theravance COM 45781M101 13,750 0 0.00 145 -27.50 0.0035
2019-08-13 2019-06-30 13F Theravance COM 45781M101 13,750 0 0.00 200 3.63 0.0049
2019-05-13 2019-03-31 13F Theravance COM 45781M101 13,750 0 0.00 193 -19.58 0.0048
2019-02-13 2018-12-31 13F Theravance COM 45781M101 13,750 0 0.00 240 14.29 0.0068
2018-11-14 2018-09-30 13F Theravance COM 45781M101 13,750 2,662 24.01 210 37.25 0.0050
2018-08-13 2018-06-30 13F Theravance COM 45781M101 11,088 0 0.00 153 -17.30 0.0039
2018-05-10 2018-03-31 13F Theravance COM 45781M101 11,088 22 0.20 185 17.83 0.0050
2018-02-24 2017-12-31 13F/A-1 Theravance COM 45781M101 11,066 2,552 29.97 157 30.83 0.0043
2018-02-22 2017-12-31 13F Theravance COM 45781M101 8,048 -466 114
2017-11-14 2017-09-30 13F Theravance COM 45781M101 8,514 638 8.10 120 18.81 0.0035
2017-08-14 2017-06-30 13F Theravance COM 45781M101 7,876 3,652 86.46 101 71.19 0.0030
2017-05-03 2017-03-31 13F Theravance COM 45781M101 4,224 4,224 59 0.0018
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.